PharmaNutra
€70.50Change from previous close: −0.98%Absolute change: −€0.70
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- €675.05M
- Enterprise value
- €684.97M
- P/E (trailing 12 months)
- 32.5
- Forward P/E
- 22.6
- Price/book
- 9.71
- Price/sales
- 4.70
- EV/EBITDA
- 20.6
- EV/revenue
- 4.77
Profitability and growth
- Gross margin
- 50.3%
- Operating margin
- 24.6%
- Net margin
- 14.4%
- ROE
- 31.6%
- ROA
- 16.2%
- Revenue growth (year over year)
- 13.3%
- Earnings growth (year over year)
- -5.3%
Financial health
- Total cash
- €15.14M
- Total debt
- €18.36M
- Debt/equity
- 0.26
- Current ratio
- 2.05
- Quick ratio
- 1.51
Dividends
- Annual dividend per share
- €1.20
- Dividend yield
- 1.7%
- Payout ratio
- 55.3%
- Ex-dividend date
- May 4, 2026
Analysts and estimates
- Average price target
- €95.67
- Median price target
- €93.00
- High price target
- €102.00
- Low price target
- €92.00
- Analysts with a price target
- 3
- Forward EPS
- €3.13
- EPS estimate, current year
- €2.47
Shares and trading
- Beta
- 0.16
- Average volume
- 12.68K
- Shares outstanding
- 9.58M
- Float
- 3.27M
- Institutional ownership
- 16.2%
- Insider ownership
- 65.0%